Literature DB >> 22783427

Acquisition of anoikis resistance through CD147 upregulation: A new mechanism underlying metastasis of hepatocellular carcinoma cells.

Xia Ke1, Ling Li, Hong-Lin Dong, Zhi-Nan Chen.   

Abstract

Acquisition of anoikis resistance is a prerequisite for the metastasis of hepatocellular carcinoma (HCC) cells. Activation of growth factor signaling pathways and rearrangement of the cytoskeleton have been reported as vital steps in this process. However, key molecules involved in anoikis resistance remain to be determined. The aim of this study was to investigate the effect of CD147 on HCC cells resistant to anoikis. The human SMMC-7221 human HCC cell line was used. Immunofluorescence was used to investigate the expression levels of CD147. Anoikis-induced cell death was assessed using trypan blue exclusion. In the present study, the results showed that SMMC-7721 HCC cells exhibited significant morphological changes when suspended in culture medium supplemented with 1% methocel and a subpopulation of cells resistant to anoikis was acquired with higher viability and invasion ability. CD147 was identified to be significantly increased in cells resistant to anoikis, when compared to the parental cells. CD147 knockdown by siRNA notably induced cell anoikis, partially through the inactivation of PI3K/Akt pathway. All of these evidence provide a novel CD147-related mechanism underlying the metastasis of HCC cells.

Entities:  

Year:  2012        PMID: 22783427      PMCID: PMC3392584          DOI: 10.3892/ol.2012.658

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  36 in total

1.  A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation.

Authors:  Jing Xu; Zhong-Yang Shen; Xin-Guo Chen; Qing Zhang; Hui-Jie Bian; Ping Zhu; Hui-Yun Xu; Fei Song; Xiang-Min Yang; Li Mi; Qing-Chuan Zhao; Rong Tian; Qiang Feng; Si-He Zhang; Yu Li; Jian-Li Jiang; Ling Li; Xiao-Ling Yu; Zheng Zhang; Zhi-Nan Chen
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

2.  All-trans-retinoic acid increased the expression of integrin alpha5beta1 and induced "anoikis" in SMMC-7721 hepatocarcinoma cell.

Authors:  Y Feng; L Y Wang; T Cai; J W Jin; G F Zhou; L H Cao; X L Zha
Journal:  J Exp Clin Cancer Res       Date:  2001-09

3.  Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase.

Authors:  A McFall; A Ulkü; Q T Lambert; A Kusa; K Rogers-Graham; C J Der
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

4.  E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.

Authors:  Hyung-Gyoo Kang; Jasmine M Jenabi; Jingsong Zhang; Nino Keshelava; Hiroyuki Shimada; William A May; Tony Ng; C Patrick Reynolds; Timothy J Triche; Poul H B Sorensen
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

5.  HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.

Authors:  J Wu; N-Y Ru; Y Zhang; Y Li; D Wei; Z Ren; X-F Huang; Z-N Chen; H Bian
Journal:  Oncogene       Date:  2011-05-02       Impact factor: 9.867

6.  The integrin-linked kinase (ILK) suppresses anoikis.

Authors:  S Attwell; C Roskelley; S Dedhar
Journal:  Oncogene       Date:  2000-08-03       Impact factor: 9.867

7.  Curcumin sensitizes non-small cell lung cancer cell anoikis through reactive oxygen species-mediated Bcl-2 downregulation.

Authors:  Varisa Pongrakhananon; Ubonthip Nimmannit; Sudjit Luanpitpong; Yon Rojanasakul; Pithi Chanvorachote
Journal:  Apoptosis       Date:  2010-05       Impact factor: 4.677

8.  HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.

Authors:  Jing Xu; Hui-Yun Xu; Qing Zhang; Fei Song; Jian-Li Jiang; Xiang-Min Yang; Li Mi; Ning Wen; Rong Tian; Li Wang; Hui Yao; Qiang Feng; Yang Zhang; Jin-Liang Xing; Ping Zhu; Zhi-Nan Chen
Journal:  Mol Cancer Res       Date:  2007-06       Impact factor: 5.852

9.  B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis.

Authors:  K Boisvert-Adamo; A E Aplin
Journal:  Oncogene       Date:  2006-03-20       Impact factor: 9.867

10.  Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation.

Authors:  Imtiaz A Mawji; Craig D Simpson; Rose Hurren; Marcela Gronda; Moyo A Williams; Jorge Filmus; James Jonkman; Ralph S Da Costa; Brian C Wilson; Michael P Thomas; John C Reed; Gennadi V Glinsky; Aaron D Schimmer
Journal:  J Natl Cancer Inst       Date:  2007-05-16       Impact factor: 13.506

View more
  17 in total

1.  HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.

Authors:  Ling Li; Wenhua Tang; Xiaoqing Wu; David Karnak; Xiaojie Meng; Rachel Thompson; Xinbao Hao; Yongmin Li; Xiaotan T Qiao; Jiayuh Lin; James Fuchs; Diane M Simeone; Zhi-Nan Chen; Theodore S Lawrence; Liang Xu
Journal:  Clin Cancer Res       Date:  2013-10-16       Impact factor: 12.531

2.  Upregulation of CD147 protects hepatocellular carcinoma cell from apoptosis through glycolytic switch via HIF-1 and MCT-4 under hypoxia.

Authors:  Xia Ke; Yanke Chen; Pei Wang; Jinliang Xing; Zhinan Chen
Journal:  Hepatol Int       Date:  2014-05-03       Impact factor: 6.047

Review 3.  Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease.

Authors:  Christopher Gromisch; Motaz Qadan; Mariana Albuquerque Machado; Kebin Liu; Yolonda Colson; Mark W Grinstaff
Journal:  Cancer Res       Date:  2020-03-27       Impact factor: 12.701

4.  Safety and efficacy of a peripheral intravenous bolus of Licartin for the treatment of advanced hepatocellular carcinoma.

Authors:  Dong Dai; Wengui Xu; Jianjing Liu; Lei Zhu; Xiang Zhu; Xiaoying Ma
Journal:  Exp Ther Med       Date:  2013-09-30       Impact factor: 2.447

Review 5.  The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature.

Authors:  Lijuan Xiong; Carl K Edwards; Lijun Zhou
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

6.  Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft.

Authors:  Ruzila Ismail; Zeenathul Nazariah Allaudin; Rasedee Abdullah; Mohd-Azmi Mohd Lila; Nik-Mohd-Afizan Nik Abd Rahman; Sheikh-Omar Abdul Rahman
Journal:  BMC Cancer       Date:  2016-07-13       Impact factor: 4.430

7.  The fucosylated CD147 enhances the autophagy in epithelial ovarian cancer cells.

Authors:  Zhenhua Hu; Mingbo Cai; Lu Deng; Liancheng Zhu; Jian Gao; Mingzi Tan; Juanjuan Liu; Bei Lin
Journal:  Oncotarget       Date:  2016-12-13

Review 8.  Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development.

Authors:  Thomas Tu; Magdalena A Budzinska; Annette E Maczurek; Robert Cheng; Anna Di Bartolomeo; Fiona J Warner; Geoffrey W McCaughan; Susan V McLennan; Nicholas A Shackel
Journal:  Int J Mol Sci       Date:  2014-05-27       Impact factor: 5.923

9.  miR-92a promotes hepatocellular carcinoma cells proliferation and invasion by FOXA2 targeting.

Authors:  Liang Wang; Jinhong Wu; Changao Xie
Journal:  Iran J Basic Med Sci       Date:  2017-07       Impact factor: 2.699

Review 10.  The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters.

Authors:  Xiaofeng Li; Xiaozhou Yu; Dong Dai; Xiuyu Song; Wengui Xu
Journal:  Oncotarget       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.